v3.26.1
Interim Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 671 $ 670
Restricted cash and restricted cash equivalents 0 2
Accounts and notes receivable, net 907 679
Inventories 1,452 1,569
Prepaid expenses and other 63 80
Assets held for sale 1 1
Total current assets 3,094 3,001
Property, plant, and equipment 9,993 9,920
Less: Accumulated depreciation (6,965) (6,842)
Property, plant, and equipment, net 3,028 3,078
Operating lease right-of-use assets 270 271
Goodwill 46 46
Other intangible assets, net 2 2
Investments in affiliates 170 160
Assets held for sale, non-current 0 21
Restricted cash and restricted cash equivalents 52 52
Other assets 488 751
Total assets 7,150 7,382
Current liabilities:    
Accounts payable 937 954
Compensation and other employee-related cost 83 96
Short-term and current maturities of long-term debt 34 42
Current environmental remediation 124 88
Other accrued liabilities 683 506
Total current liabilities 1,861 1,686
Long-term debt, net 3,838 4,099
Operating lease liabilities 191 191
Long-term environmental remediation 671 530
Deferred income taxes 64 37
Other liabilities 573 588
Total liabilities 7,198 7,131
Commitments and contingent liabilities
Equity    
Common stock (par value $0.01 per share; 810,000,000 shares authorized; 199,276,562 shares issued and 150,463,268 shares outstanding at June 30, 2026; 198,720,786 shares issued and 149,893,993 shares outstanding at December 31, 2025) 2 2
Treasury stock, at cost (48,813,294 shares at June 30, 2026 and 48,826,793 at December 31, 2025) (1,801) (1,802)
Additional paid-in capital 1,088 1,074
Retained earnings 891 1,220
Accumulated other comprehensive loss (229) (244)
Total Chemours stockholders’ equity (49) 250
Non-controlling interests 1 1
Total equity (48) 251
Total liabilities and equity $ 7,150 $ 7,382